These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 38454277)
21. Alternative splicing of NUMB, APP and VEGFA as the features of pancreatic ductal carcinoma. Zheng KL; He TL; Ji WP; Jiang H; Shen Y; Li G; Zhu SB; Tong BL; Zhang YJ Int J Clin Exp Pathol; 2015; 8(6):6181-91. PubMed ID: 26261495 [TBL] [Abstract][Full Text] [Related]
22. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer. Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172 [TBL] [Abstract][Full Text] [Related]
23. Identification of significant prognostic risk markers for pancreatic ductal adenocarcinoma: a bioinformatic analysis. Zhang Z; Sun W; Zeng Z; Lu Y Acta Biochim Pol; 2022 Jun; 69(2):327-333. PubMed ID: 35675627 [TBL] [Abstract][Full Text] [Related]
24. MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7. Xu C; Qi X J Clin Lab Anal; 2020 Oct; 34(10):e23442. PubMed ID: 32592206 [TBL] [Abstract][Full Text] [Related]
25. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763 [TBL] [Abstract][Full Text] [Related]
26. Construction of a prognostic prediction system for pancreatic ductal adenocarcinoma to investigate the key prognostic genes. Zheng B; Peng J; Mollayup A; Bakri A; Guo L; Zheng J; Xu H Mol Med Rep; 2018 Jan; 17(1):216-224. PubMed ID: 29115420 [TBL] [Abstract][Full Text] [Related]
27. Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma. Yang MW; Tao LY; Jiang YS; Yang JY; Huo YM; Liu DJ; Li J; Fu XL; He R; Lin C; Liu W; Zhang JF; Hua R; Li Q; Jiang SH; Hu LP; Tian GA; Zhang XX; Niu N; Lu P; Shi J; Xiao GG; Wang LW; Xue J; Zhang ZG; Sun YW Cancer Res; 2020 May; 80(10):1991-2003. PubMed ID: 32098780 [TBL] [Abstract][Full Text] [Related]
28. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. Yan C; Niu Y; Li F; Zhao W; Ma L J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146 [TBL] [Abstract][Full Text] [Related]
29. The long non-coding RNA DKFZp434J0226 regulates the alternative splicing process through phosphorylation of SF3B6 in PDAC. Li J; Tong H; Li D; Jiang Q; Zhang Y; Tang W; Jin D; Chen S; Qin X; Zhang S; Xue R Mol Med; 2021 Aug; 27(1):95. PubMed ID: 34470609 [TBL] [Abstract][Full Text] [Related]
30. Kif20a inhibition reduces migration and invasion of pancreatic cancer cells. Stangel D; Erkan M; Buchholz M; Gress T; Michalski C; Raulefs S; Friess H; Kleeff J J Surg Res; 2015 Jul; 197(1):91-100. PubMed ID: 25953216 [TBL] [Abstract][Full Text] [Related]
31. SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axis. Ma Q; Wu X; Wu J; Liang Z; Liu T Int J Oncol; 2017 Oct; 51(4):1104-1114. PubMed ID: 28902358 [TBL] [Abstract][Full Text] [Related]
32. Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. Yin Y; Zhu X; Huang S; Zheng J; Zhang M; Kong W; Chen Q; Zhang Y; Chen X; Lin K; Ouyang X Tumour Biol; 2017 Jun; 39(6):1010428317699131. PubMed ID: 28618924 [TBL] [Abstract][Full Text] [Related]
33. CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma. Yang G; Wang Y; Xiao J; Zhao F; Qiu J; Liu Y; Chen G; Cao Z; You L; Zheng L; Zhang T; Zhao Y Cell Oncol (Dordr); 2021 Apr; 44(2):345-355. PubMed ID: 33125631 [TBL] [Abstract][Full Text] [Related]
34. Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer. Dang C; Zhang Y; Ma Q; Shimahara Y J Gastroenterol Hepatol; 2006 May; 21(5):850-8. PubMed ID: 16704535 [TBL] [Abstract][Full Text] [Related]
35. The Key Genes for Perineural Invasion in Pancreatic Ductal Adenocarcinoma Identified With Monte-Carlo Feature Selection Method. Zhu JH; Yan QL; Wang JW; Chen Y; Ye QH; Wang ZJ; Huang T Front Genet; 2020; 11():554502. PubMed ID: 33193628 [TBL] [Abstract][Full Text] [Related]
36. IL2RA is a prognostic indicator and correlated with immune characteristics of pancreatic ductal adenocarcinoma. Fan L; Wang X; Chang Q; Wang Y; Yang W; Liu L Medicine (Baltimore); 2022 Oct; 101(42):e30966. PubMed ID: 36281157 [TBL] [Abstract][Full Text] [Related]
37. Tenascin C in the Tumor-Nerve Microenvironment Enhances Perineural Invasion and Correlates With Locoregional Recurrence in Pancreatic Ductal Adenocarcinoma. Furuhashi S; Sakaguchi T; Murakami T; Fukushima M; Morita Y; Ikegami K; Kikuchi H; Setou M; Takeuchi H Pancreas; 2020 Mar; 49(3):442-454. PubMed ID: 32132519 [TBL] [Abstract][Full Text] [Related]
38. Relationship between autophagy and perineural invasion, clinicopathological features, and prognosis in pancreatic cancer. Yang YH; Liu JB; Gui Y; Lei LL; Zhang SJ World J Gastroenterol; 2017 Oct; 23(40):7232-7241. PubMed ID: 29142470 [TBL] [Abstract][Full Text] [Related]
39. Immune-related genes Zhang M; Zeng L; Peng Y; Fan B; Chen P; Liu J Future Oncol; 2021 Aug; 17(23):3061-3076. PubMed ID: 34156282 [TBL] [Abstract][Full Text] [Related]
40. Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma. Reiser-Erkan C; Erkan M; Pan Z; Bekasi S; Giese NA; Streit S; Michalski CW; Friess H; Kleeff J Cancer Biol Ther; 2008 Sep; 7(9):1352-9. PubMed ID: 18708761 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]